版本:
中国

BRIEF-Caladrius subsidiary, PCT, announces 5-year strategic manufacturing services agreement with Adaptimmune

Sept 19 Caladrius Biosciences Inc

* Caladrius Subsidiary, PCT, announces five-year strategic manufacturing services agreement with Adaptimmune

* New five-year strategic manufacturing services agreement under which percent will produce SPEAR T-cell therapies for Adaptimmune Therapeutics Plc Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐